R. M. de Real

NKG2A and HLA-E define a novel alternative immune checkpoint axis in bladder cancer

Brian H. Lee, M. Carrington, M. Skobe, 2022, bioRxiv.

NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.

M. Skobe, R. Sebra, M. Galsky, 2022, Cancer cell.

Elevated HLA-E and NKG2A as a Consequence of Chronic Immune Activation Defines Resistance to M. bovis BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer

O. Elemento, R. Sebra, H. Ravichandran, 2022, bioRxiv.

A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID‐19

M. Merad, Assaf Magen, A. Charney, 2021, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Understanding the heterogeneity of alloreactive natural killer cell function in kidney transplantation

P. Cravedi, S. Kim-Schulze, M. Fribourg, 2023, bioRxiv.